trial · primary record
TSLPR-CART
B-All
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 57 |
| Primary completion | 2032-06-30 |
| Primary endpoint | To assess the safety of administering escalating doses of TSLPR-CART containing a tEGFR suicide switch to determine an MTD |
| Registry ID | NCT07572136 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:06.923Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07572136
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.